Li Ning, Zhang Yu, Gao Yuan, Bai Yifan, Qiao Fan, Tan Mengwei, Han Qingqi, Lu Fanglin, Li Bailing, Han Lin, Zhang Guanxin, Xu Zhiyun
Department of Cardiothoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
J Thorac Dis. 2020 Mar;12(3):249-257. doi: 10.21037/jtd.2020.01.72.
Multiple of subsequent procedures may necessary in Marfan syndrome (MFS) patients after initial surgery. The aim of this study was to investigate the full spectrum of secondary distal vascular or valvular interventions encountered after initial surgery.
Retrospective analysis of 201 consecutive MFS patients between January 2000 and March 2019 who underwent 274 distal aortic reinterventions and 5 mitral valve replacements.
Of the enrolled 201 MFS patients (73 female, mean age 37.0±12.8 years), the surgical indication for 93 patients was aortic root aneurysm, and for another 108 patients was dissection. The mean follow-up interval was 8.4±5.5 years. Total arch replacement (TAR) was performed in 68.5% of MFS patients presenting with type A aortic dissection (TAAD) and in 2.2% of patients with aneurysm. Secondary TAR became necessary for 3.4% of patients who failed to receive TAR at initial surgery in aneurysm group during follow-up, while for 33.3% of patients in dissection group (P<0.001). Freedom from distal aortic reoperation in dissection group were 65.4%±5.2%, 49.6%±6.4%, and 38.3%±7.7% and in aneurysm group were 90.5%±3.5%, 84.2%±4.8%, and 84.2%±4.8% at 5, 10, and 15 years, respectively (P<0.001). Survival in dissection group were 94.4%±2.4%, 83.4%±5.7%, 68.4%±10.8% and in aneurysm group were 100%, 97.7%±2.3%, 97.7%±2.3% at 5, 10, and 15 years, respectively (P=0.001). Freedom from mitral valve reoperation in dissection group were 98.8%±1.2%, 98.8%±1.2%, 88.9%±9.4% at 5, 10, and 15 years, respectively. Freedom from mitral valve reoperation in aneurysm group were 97.2%±1.9%, 94.6%±3.2%, 94.6%±3.2% at 5, 10, and 15 years, respectively (P=0.775).
TAAD at initial surgery was an independent predictor of distal aortic reoperation. Limited repair was feasible for MFS patients presenting with aneurysm at initial surgery, extended repair might be better for TAAD for its higher risk of distal reintervention. Concomitant mitral valve procedures may depend on mitral regurgitation grades.
马凡综合征(MFS)患者在初次手术后可能需要多次后续手术。本研究的目的是调查初次手术后二次远端血管或瓣膜干预的全貌。
回顾性分析2000年1月至2019年3月期间连续201例接受274次远端主动脉再次干预和5次二尖瓣置换术的MFS患者。
在纳入的201例MFS患者(73例女性,平均年龄37.0±12.8岁)中,93例患者的手术指征是主动脉根部瘤,另外108例患者的手术指征是夹层。平均随访间隔为8.4±5.5年。68.5%的A型主动脉夹层(TAAD)MFS患者和2.2%的动脉瘤患者接受了全弓置换(TAR)。在随访期间,动脉瘤组中3.4%初次手术未接受TAR的患者需要二次TAR,而夹层组中这一比例为33.3%(P<0.001)。夹层组5年、10年和15年的远端主动脉再次手术-free率分别为65.4%±5.2%、49.6%±6.4%和38.3%±7.7%,动脉瘤组分别为90.5%±3.5%、84.2%±4.8%和84.2%±4.8%(P<0.001)。夹层组5年、10年和15年的生存率分别为94.4%±2.4%、83.4%±5.7%、68.4%±10.8%,动脉瘤组分别为100%、97.7%±2.3%、97.7%±2.3%(P=0.001)。夹层组5年、10年和15年的二尖瓣再次手术-free率分别为98.8%±1.2%、98.8%±1.2%、88.9%±9.4%。动脉瘤组5年、10年和15年的二尖瓣再次手术-free率分别为97.2%±1.9%、94.6%±3.2%、94.6%±3.2%(P=0.775)。
初次手术时的TAAD是远端主动脉再次手术的独立预测因素。对于初次手术时患有动脉瘤的MFS患者,有限修复是可行的,对于TAAD患者,由于其远端再次干预风险较高,扩大修复可能更好。二尖瓣同期手术可能取决于二尖瓣反流分级。